Trial Profile
A study investigating the association between hepatitis C virus genotype and hepatitis C virus RNA kinetics in liver transplant patients with hepatitis C Virus infections and who were receiving sofosbuvir (SOF) + ribavirin (RBV) treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Oct 2015
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics
- 20 Oct 2015 New trial record